Glucagon-like peptide-1, or GLP-1, has been studied by scientists for over 30 years, with the first GLP-1 receptor agonist approved for diabetes in 2005
Products containing it may be sold as cosmetics for hair and scalp appearance, but they may not lawfully claim to treat or cure a hair-loss disease without crossing into drug-regulation territory
In other words, the liver benefits are not simply a downstream consequence of losing weight
July 23, 2026 The value of the global ice cream market is going up in value
Side effects linked to low-fat intake Patients who consume too little fat can experience irregular absorption, which may alter triglyceride levels and overall efficacy
The dose starts low at 0.25 mg and is gradually increased until you reach a maximum of 2.4 mg to help reduce any side effects